11/14/2024
11:17 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
CVI Investments, Inc. (Filed by)
| Form SC 13G/A | |
11/01/2024
3:05 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
9:12 AM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 424B5 | |
10/01/2024
3:02 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
9:22 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
CVI Investments, Inc. (Filed by)
| Form SC 13G | |
09/12/2024
3:25 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
7:50 AM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
7:50 AM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
4:00 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
3:30 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
3:10 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
7:58 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
L5 Capital Inc. (Filed by)
| Form SC 13D/A | |
05/17/2024
3:51 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:10 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 424B5 | |
03/18/2024
4:15 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/31/2024
11:15 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form EFFECT | |
01/31/2024
4:24 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2024
4:00 PM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2024
10:01 AM | BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
Copia Fund LP (0001718996) (Filed by)
| Form SCHEDULE 13G | |
11/30/2023
6:00 AM | BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
